-
Forward Look
Double Mastectomies on the RiseStudy suggests fears rather than actual risk of recurrence drive decisions.
by Cameron Walker
-
Forward Look
Exploring the Link Between Cancer and Vitamin DQuestions remain about low vitamin D levels and cancer risk.
by Sharon Reynolds
-
Forward Look
A Deadly InflammationSepsis may be a factor in up to half of all hospital deaths.
by Alexandra Goho
-
Forward Look
Smoking After CancerA cancer diagnosis isn’t enough to convince some smokers to kick the habit. A survey of almost 3,000 survivors of the 10 most common types of cancer published in the September 2014 issue of Cancer Epidemiology, Biomarkers & Prevention found nearly one in 10 survivors were current smokers nine years after diagnosis, with 83 percent lighting […]
-
Forward Look
A Global Perspective on CancerQ&A with Christopher P. Wild on World Cancer Report 2014.
by Sue Rochman
-
Forward Look
You’ve Got MailAt-home colorectal cancer tests can increase screening rates.
by Cameron Walker
-
Forward Look
African-Americans at Higher Risk for Multiple MyelomaResearchers aim to identify possible reasons.
by Sue Rochman
-
Forward Look
The Vitamin HypeResearchers find no evidence that supplements reduce cancer risk.
by Stephen Ornes
-
A Balancing Act
Diabetes increases cancer risk, and a dual diagnosis of cancer and diabetes complicates treatment and prognosis.
by Stephen Ornes
-
Healthy Habits
A Protein PuzzleStudy links higher protein consumption to a greater chance of cancer death, but risk may depend on age.
by Alanna Kennedy-Gorman
Cancer Talk
Living With Your Loved One’s Prostate Cancer
Christine Ledbetter on the ways her husband’s prostate cancer affected their relationship and finding support as a caregiver.
by Christine Ledbetter
Continuing the ConversationThe AACR hosts a roundtable to ‘get real’ about cancer health disparities.
by Marci A. Landsmann
More Patients Participating in Cancer ResearchA higher proportion of cancer patients are enrolling in research studies than previously thought, but many patients lack the access needed to participate.
by Kyle Bagenstose
Immunotherapy Drug Tarlatamab Approved for Advanced Small Cell Lung CancerThe drug showed promise in treating small cell lung cancer that had progressed during or after chemotherapy.
by Laura Gesualdi-Gilmore